FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Marketing

Modernize DTC Ads with QR Code: WLF

A Washington Legal Foundation background document suggests that Congress change direct-to-consumer disclaimer rules to recognize the availability of s...

latest-news-card-1
Human Drugs

NIH-Funded Study to Assess GLP-1 Drugs in Alzheimers

Researchers at the University of Cincinnati begin a new study to investigate whether widely used diabetes and weight-loss drugs could help prevent or ...

latest-news-card-1
Human Drugs

FDA Says Proposed Drug Import Guidance Unwarranted

FDA denies a 2024 Aimed Alliance petition asking for a guidance on human drug importation by alternative funding programs.

latest-news-card-1
Federal Register

Mitapivat Moving Toward Accelerated Approval in Sickle Cell: Agios

Agios Pharmaceuticals says it plans to seek accelerated approval for mitapivat in sickle cell disease, following a pre-submission meeting with FDA.

latest-news-card-1
Human Drugs

FDA Warns of Serious Liver Risks Linked to Tavneos

FDA issues a safety alert warning that patients taking Amgens Tavneos (avacopan) for a rare autoimmune condition may face a risk of severe liver injur...

latest-news-card-1
FDA General

FDA Seeking Input on Expanding Digital Health Tech in Trials

Looking to modernize drug and biologic development, FDA seeks industry and public input on how to expand the use of digital health technologies in cli...

latest-news-card-1
FDA General

Scholar Rock Refiles BLA for Spinal Muscular Atrophy Therapy

Scholar Rock resubmits its BLA for apitegromab, an investigational therapy for children and adults with Spinal Muscular Atrophy.

latest-news-card-1
Biologics

Novel CAR-T Therapy Gets Breakthrough Status

A novel off-the-shelf CAR-T cell therapy developed by researchers at Washington University School of Medicine in St. Louis receives an FDA breakthroug...

latest-news-card-1
Human Drugs

FDA Pharma Disclosures Raise Transparency-Confidentiality Tensions

FDA's more aggressive approach to publicizing its criticisms of drugmakers draws both praise from investors and concern across the pharmaceutical indu...

latest-news-card-1
Human Drugs

FDA Records Reveal Lapses in Drug Safety Checks: Analysis

FDA inspection records show that some generic drug manufacturers are routinely failing to carry out basic safety and quality checks.